xtalpi enabled pharmaengine pep08 achieves enrollment milestone with second synthetic lethality program underway

TAX_DISEASE_CANCERTAX_DISEASE_PANCREATIC_ADENOCARCINOMATAX_DISEASE_ADENOCARCINOMALEADER

The full article is on the original publisher site. This page only shows the headline and a very short excerpt.